Blood sugar drug tirzepatide also leads to substantial weight loss in diabetes patients, Eli Lilly says

There's more evidence that the injectable drug tirzepatide helps people with diabetes lose weight as well as control their blood sugar, according to the drug's manufacturer, Eli Lilly and Company.In a new study, more than 900 adults with obesity and diabetes took the drug for a year and five months, and those on the highest dose lost an average of 34 pounds, or nearly 16% of their starting weight.

Read at www.cnn.com